A detailed history of Alley Investment Management Company, LLC transactions in Amgen Inc stock. As of the latest transaction made, Alley Investment Management Company, LLC holds 23,478 shares of AMGN stock, worth $6.18 Million. This represents 0.96% of its overall portfolio holdings.

Number of Shares
23,478
Previous 23,096 1.65%
Holding current value
$6.18 Million
Previous $7.22 Million 4.82%
% of portfolio
0.96%
Previous 0.99%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$309.38 - $337.38 $118,183 - $128,879
382 Added 1.65%
23,478 $7.56 Million
Q2 2024

Aug 14, 2024

BUY
$262.75 - $319.31 $757,245 - $920,251
2,882 Added 14.26%
23,096 $7.22 Million
Q1 2024

May 10, 2024

SELL
$268.87 - $324.56 $16,401 - $19,798
-61 Reduced 0.3%
20,214 $5.75 Million
Q4 2023

Feb 12, 2024

SELL
$255.7 - $288.46 $113,530 - $128,076
-444 Reduced 2.14%
20,275 $5.84 Million
Q3 2023

Oct 27, 2023

BUY
$218.65 - $271.46 $70,186 - $87,138
321 Added 1.57%
20,719 $5.57 Million
Q2 2023

Aug 11, 2023

BUY
$214.27 - $253.37 $50,567 - $59,795
236 Added 1.17%
20,398 $4.53 Million
Q1 2023

May 12, 2023

BUY
$225.79 - $275.2 $240,692 - $293,363
1,066 Added 5.58%
20,162 $4.87 Million
Q4 2022

Feb 07, 2023

BUY
$229.03 - $291.01 $55,425 - $70,424
242 Added 1.28%
19,096 $5.02 Million
Q3 2022

Oct 27, 2022

BUY
$224.46 - $253.15 $27,833 - $31,390
124 Added 0.66%
18,854 $4.25 Million
Q2 2022

Aug 05, 2022

BUY
$230.71 - $256.74 $65,060 - $72,400
282 Added 1.53%
18,730 $4.56 Million
Q1 2022

May 10, 2022

BUY
$219.27 - $242.57 $4.05 Million - $4.47 Million
18,448 New
18,448 $4.46 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Alley Investment Management Company, LLC Portfolio

Follow Alley Investment Management Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alley Investment Management Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alley Investment Management Company, LLC with notifications on news.